These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 35745275

  • 1. Human Milk Oligosaccharides and Lactose Differentially Affect Infant Gut Microbiota and Intestinal Barrier In Vitro.
    Natividad JM, Marsaux B, Rodenas CLG, Rytz A, Vandevijver G, Marzorati M, Van den Abbeele P, Calatayud M, Rochat F.
    Nutrients; 2022 Jun 19; 14(12):. PubMed ID: 35745275
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of Human Milk Oligosaccharides on the Adult Gut Microbiota and Barrier Function.
    Šuligoj T, Vigsnæs LK, Abbeele PVD, Apostolou A, Karalis K, Savva GM, McConnell B, Juge N.
    Nutrients; 2020 Sep 13; 12(9):. PubMed ID: 32933181
    [Abstract] [Full Text] [Related]

  • 5. Linking Human Milk Oligosaccharides, Infant Fecal Community Types, and Later Risk To Require Antibiotics.
    Berger B, Porta N, Foata F, Grathwohl D, Delley M, Moine D, Charpagne A, Siegwald L, Descombes P, Alliet P, Puccio G, Steenhout P, Mercenier A, Sprenger N.
    mBio; 2020 Mar 17; 11(2):. PubMed ID: 32184252
    [Abstract] [Full Text] [Related]

  • 6. Blends of Human Milk Oligosaccharides Confer Intestinal Epithelial Barrier Protection in Vitro.
    Natividad JM, Rytz A, Keddani S, Bergonzelli G, Garcia-Rodenas CL.
    Nutrients; 2020 Oct 05; 12(10):. PubMed ID: 33027993
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Sialyllactose and Galactooligosaccharides Promote Epithelial Barrier Functioning and Distinctly Modulate Microbiota Composition and Short Chain Fatty Acid Production In Vitro.
    Perdijk O, van Baarlen P, Fernandez-Gutierrez MM, van den Brink E, Schuren FHJ, Brugman S, Savelkoul HFJ, Kleerebezem M, van Neerven RJJ.
    Front Immunol; 2019 Oct 05; 10():94. PubMed ID: 30809221
    [Abstract] [Full Text] [Related]

  • 11. In vitro fermentation of human milk oligosaccharides by individual Bifidobacterium longum-dominant infant fecal inocula.
    Li H, Lane JA, Chen J, Lu Z, Wang H, Dhital S, Fu X, Huang Q, Liu F, Zhang B.
    Carbohydr Polym; 2022 Jul 01; 287():119322. PubMed ID: 35422288
    [Abstract] [Full Text] [Related]

  • 12. Impact of dietary fibers in infant formulas on gut microbiota and the intestinal immune barrier.
    Kong C, Faas MM, de Vos P, Akkerman R.
    Food Funct; 2020 Nov 18; 11(11):9445-9467. PubMed ID: 33150902
    [Abstract] [Full Text] [Related]

  • 13. Structure-function relationship and impact on the gut-immune barrier function of non-digestible carbohydrates and human milk oligosaccharides applicable for infant formula.
    Chen X, de Vos P.
    Crit Rev Food Sci Nutr; 2024 Nov 18; 64(23):8325-8345. PubMed ID: 37035930
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Oral supplementation of healthy adults with 2'-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota.
    Elison E, Vigsnaes LK, Rindom Krogsgaard L, Rasmussen J, Sørensen N, McConnell B, Hennet T, Sommer MO, Bytzer P.
    Br J Nutr; 2016 Oct 18; 116(8):1356-1368. PubMed ID: 27719686
    [Abstract] [Full Text] [Related]

  • 16. Gastrointestinal barrier function, immunity, and neurocognition: The role of human milk oligosaccharide (hMO) supplementation in infant formula.
    Kassai S, de Vos P.
    Compr Rev Food Sci Food Saf; 2024 Jan 18; 23(1):e13271. PubMed ID: 38284595
    [Abstract] [Full Text] [Related]

  • 17. Activation of the G-protein coupled receptor GPR35 by human milk oligosaccharides through different pathways.
    Foata F, Sprenger N, Rochat F, Damak S.
    Sci Rep; 2020 Sep 30; 10(1):16117. PubMed ID: 32999316
    [Abstract] [Full Text] [Related]

  • 18. Diversification of a Fucosyllactose Transporter within the Genus Bifidobacterium.
    Ojima MN, Asao Y, Nakajima A, Katoh T, Kitaoka M, Gotoh A, Hirose J, Urashima T, Fukiya S, Yokota A, Abou Hachem M, Sakanaka M, Katayama T.
    Appl Environ Microbiol; 2022 Jan 25; 88(2):e0143721. PubMed ID: 34731055
    [Abstract] [Full Text] [Related]

  • 19. The Role of Two Human Milk Oligosaccharides, 2'-Fucosyllactose and Lacto-N-Neotetraose, in Infant Nutrition.
    Hegar B, Wibowo Y, Basrowi RW, Ranuh RG, Sudarmo SM, Munasir Z, Atthiyah AF, Widodo AD, Supriatmo, Kadim M, Suryawan A, Diana NR, Manoppo C, Vandenplas Y.
    Pediatr Gastroenterol Hepatol Nutr; 2019 Jul 25; 22(4):330-340. PubMed ID: 31338308
    [Abstract] [Full Text] [Related]

  • 20. Factors affecting early-life intestinal microbiota development.
    Vandenplas Y, Carnielli VP, Ksiazyk J, Luna MS, Migacheva N, Mosselmans JM, Picaud JC, Possner M, Singhal A, Wabitsch M.
    Nutrition; 2020 Oct 25; 78():110812. PubMed ID: 32464473
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.